cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Neoleukin Therapeutics Inc
8 own
14 watching
Current Price
$0
$0.02
(4.07%)
logo-nltx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
25.13M
52-Week High
52-Week High
3.4
52-Week Low
52-Week Low
0.375
Average Volume
Average Volume
0.17M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization25.13M
icon52-Week High3.4
icon52-Week Low0.375
iconAverage Volume0.17M
iconDividend Yield--
iconP/E Ratio--
What does the Neoleukin Therapeutics Inc do?
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
Read More
How much money does Neoleukin Therapeutics Inc make?
News & Events about Neoleukin Therapeutics Inc.
Globe Newswire
1month ago
Targeted, precision-tuned agonist of IL-2 receptor selectively expands regulatory T cellsSEATTLE, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., Neoleukin (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics...
Ticker Report
2 months ago
HC Wainwright cut shares of Neoleukin Therapeutics (NASDAQ:NLTX Get Rating) from a buy rating to a neutral rating in a research report report published on Wednesday morning, The Fly reports. HC Wainwright also issued estimates for Neoleukin Therapeutics Q2 2023 earnings at ($0.17) EPS...
Globe Newswire
3 months ago
SEATTLE, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., Neoleukin (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced an oral presentation at the upcoming American Society of Hematology (ASH...
Zolmax
8 months ago
Zacks Investment Research cut shares of Neoleukin Therapeutics (NASDAQ:NLTX Get Rating) from a buy rating to a hold rating in a research report report published on Friday morning, Zacks.com reports. According to Zacks, Neoleukin Therapeutics Inc. is a biopharmaceutical company. It is engaged in ...
Globe Newswire
9 months ago
- NL-201 demonstrates antitumor activity in preclinical B-cell lymphoma models - - NL-201 synergizes with radiation therapy to generate potent, antitumor immunity - SEATTLE, April 13, 2022 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., Neoleukin (NASDAQ:NLTX), a biopharmaceutical company ...
Frequently Asked Questions
Frequently Asked Questions
What is Neoleukin Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Neoleukin Therapeutics Inc shares?
plus_minus_icon
How can I buy Neoleukin Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Neoleukin Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Neoleukin Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Neoleukin Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Neoleukin Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Neoleukin Therapeutics Inc?
plus_minus_icon
What percentage is Neoleukin Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Neoleukin Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.02
(4.07%)
logo-nltx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00